Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-09T19:59:59.000Z.
Quote observation: 2026-09-09T19:59:59.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b4a399992bd6703193924f0814cf522aafc7389420ebb7c81270b15ae10c36e0
PEG RATIO
N/A
Centene Corp.
Market Cap
$31.66B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Centene Corp. (CNC) | $31.66B | N/A |
| DexCom, Inc. (DXCM)vs › | $31.65B | N/A |
| ResMed Inc. (RMD)vs › | $31.91B | N/A |
| Biogen Inc. (BIIB)vs › | $31.14B | N/A |
| Zoetis Inc. (ZTS)vs › | $30.74B | N/A |
| Waters Corporation (WAT)vs › | $30.28B | N/A |
| Alcon Inc. (ALC)vs › | $33.37B | N/A |
| GE HealthCare Technologies Inc. (GEHC)vs › | $29.44B | N/A |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $34.52B | N/A |
| Medline Inc. (MDLN)vs › | $28.79B | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
